A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered to Patients with Phlebotomy Dependent Polycythemia Vera (PD-PV)

Protocol No
IONIS-ISIS-702843-CS4-PV
Phase
II
Summary

This project is being done to test a new treatment ISIS 702843 for treatment of Phlebotomy-Dependent Polycythemia Vera.

Description
A Study to Evaluate Sapablursen in Patients With Polycythemia Vera
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer, Leukemia, Hematologic/Blood Related Cancers, Other Blood Related
ClinicalTrials.gov
go to website